Exane Derivatives’s DPCM Capital, Inc. XPOA Stock Holding History

Exane Derivatives’s Portfolio XPOA Stock Details XPOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-80,000	Closed	-$790K	–	1085
2021 Q2	$790K	Hold	80,000	–	–	0.18%	109
2021 Q1	$789K	Buy	+80,000	New	+$845K	0.23%	97

Other funds holding XPOA

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Exane Derivatives's XPOA Position: Q3 2021 in Review

Exane Derivatives sold out of DPCM Capital, Inc. (XPOA) in Q3 2021, closing a stake of 80,000 shares — an estimated $790K sold.

Exane Derivatives first reported a position in XPOA in Q1 2021 and held it in 2 quarters. The position peaked at $790K in Q2 2021. 85 funds tracked by Wall St. Rank hold XPOA as of Q3 2021.

Exane Derivatives reported no remaining DPCM Capital, Inc. position as of Q3 2021 after selling out during the quarter.
Exane Derivatives sold 80,000 DPCM Capital, Inc. shares in Q3 2021, an estimated $790K.
Exane Derivatives first reported a position in DPCM Capital, Inc. in Q1 2021 and held it in 2 quarters.
Exane Derivatives's DPCM Capital, Inc. position peaked at $790K in Q2 2021.
85 funds tracked by Wall St. Rank held DPCM Capital, Inc. as of Q3 2021.

Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.